Implementing Cost Reduction Strategies for HuMab Manufacturing Processes

BioProcess International

Home | Downstream | Upstream | Manufacturing | Archive

Purification

Implementing Cost Reduction Strategies for HuMab Manufacturing Processes

Arunakumari Alahari

BioProcess International, February 2009

To keep up with increasing clinical demand, antibody manufacturers are forced to adapt their methods to increase production without increasing costs. In this informative paper, Dr. Arunakumari Alahari, Senior Director of Process Development at Medarex, Inc., discusses several processes that can be implemented to reduce costs of manufacturing, including:

Perfusion Process for Cell Line Amplification
Perfusion Process for Cell Bank Preparation
CHO Production Using In-House Medium
High Capacity Non-Protein A Purification Processes

Read the full article to discover how innovative technologies and effective regulatory strategies can accelerate process development and reduce time-to-market.

Targeted BPI Content

A Single-Use, Scalable Perfusion Bioreactor System
BioProcess International, June 2009
Learn more.

A Bioreactor System Based on a Novel Oxygen Transfer Method
BioProcess International, June 2008
Learn more.

Determining the Effect of Raw Materials on Manufacturing-Scale Cell-Culture Performance
An Application of Mechanistic Mathematical Models
BioProcess International, June 2008
Learn more.

A Review of Therapeutic Protein Expression By Mammalian Cells
BioProcess International, June 2008
Learn more.

Analytical Technology and PAT
BioProcess International, January 2007
Learn more.

Bioreactor Monitoring, Modeling, and Simulation
BioProcess International, January 2007
Learn more.

Whole-Genome Evolution Technology
Improving Protein and Antibody Yields in Scalable Mammalian-Cell-Based Manufacturing
BioProcess International, May 2006
Learn more.